Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Inflammatory Bowel Disease |
📓
Gut Microbiota Profile in Pediatric Patients With Inflammatory Bowel Disease: A Systematic Review. Frontiers in pediatrics (Front Pediatr ) Vol: 9 Issue Pages: 626232 Pub: 2021 Epub: 2021 Feb 2 Authors Zhuang X , Liu C , Zhan S , Tian Z , Li N , Mao R , Zeng Z , Chen M , Html Article Publication |
| Inflammatory Bowel Disease |
📓
In Vitro Characterization of Gut Microbiota-Derived Commensal Strains: Selection of Parabacteroides distasonis Strains Alleviating TNBS-Induced Colitis in Mice. Cells (Cells ) Vol: 9 Issue 9 Pages: Pub: 2020 Sep 16 Epub: 2020 Sep 16 Authors Cuffaro B , Assohoun ALW , Boutillier D , Súkeníková L , Desramaut J , Boudebbouze S , Salomé-Desnoulez S , Hrdý J , Waligora-Dupriet AJ , Maguin E , Grangette C , Html Article Publication |
| Inflammatory Bowel Disease |
📓
Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences. United European gastroenterology journal (United European Gastroenterol J ) Vol: 7 Issue 8 Pages: 1008-1032 Pub: 2019 Oct Epub: 2019 Aug 1 Authors Salem F , Kindt N , Marchesi JR , Netter P , Lopez A , Kokten T , Danese S , Jouzeau JY , Peyrin-Biroulet L , Moulin D , Html Article Publication |
| Inflammatory Bowel Disease |
📓
Humoral immune responses against gut bacteria in dogs with inflammatory bowel disease. PloS one (PLoS One ) Vol: 14 Issue 8 Pages: e0220522 Pub: 2019 Epub: 2019 Aug 1 Authors Soontararak S , Chow L , Johnson V , Coy J , Webb C , Wennogle S , Dow S , Html Article Publication |
| Inflammatory Bowel Disease |
📓
Strain-Specific Anti-inflammatory Properties of Two <i>Akkermansia muciniphila</i> Strains on Chronic Colitis in Mice. Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 9 Issue Pages: 239 Pub: 2019 Epub: 2019 Jul 5 Authors Zhai R , Xue X , Zhang L , Yang X , Zhao L , Zhang C , Html Article Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
